Challenges in Studying Dirofilaria and Diagnostic Approaches
Historically, studying Dirofilaria in humans has been extremely difficult due to the inability to reliably identify infected individuals. Without confirmed cases to observe, meaningful study of the disease’s pathology is nearly impossible. Therefore, the first priority must be developing a reliable diagnostic test to identify a human cohort for research.
HDRI is actively exploring various diagnostic tools and technologies that may prove effective. Below are some promising avenues under investigation:
1. Near-Infrared Imaging
Near-infrared (NIR) imaging can visualize the vascular system beneath the skin. If the specific spectroscopic signatures (absorption or emission frequencies) of adult Dirofilaria can be identified especially the unique carbohydrates used to cloak themselves from the immune system it may be possible to design imaging systems that detect them directly.
By analyzing displacement of hemoglobin and using AI to distinguish between spectroscopic signals, this method could potentially detect chronic infections and track disease progression. To advance this approach, HDRI needs access to carbohydrate samples from Dirofilaria for spectroscopic analysis to identify optimal detection frequencies.
2. Filarial Test Kit Analysis
Many existing animal test kits, particularly those used for felines which often harbor occult infections similar to humans should be evaluated for human application. However, conventional antigen-based tests frequently fail, as the filaria suppress the host’s immune response, preventing detectable reactions.
A more reliable strategy involves detecting Circulating Filarial Antigens (CFA) using molecular diagnostic tools. Since the immune system often fails to respond to the infection, relying on immune reactivity is likely to yield false negatives. Molecular testing for filarial antigens directly in the blood offers a more dependable diagnostic route.
3. RT-qPCR and LAMP Diagnostics
Filaria secrete microRNAs encapsulated in emposome-like vesicles, which are absorbed by host cells and manipulated to benefit the parasite. By using reverse transcriptase to convert these RNAs into DNA, it becomes possible to amplify and detect specific DNA sequences unique to Dirofilaria. A confirmed match would provide definitive evidence of infection.
This method, however, requires specialized equipment and stringent contamination controls to prevent false positives. HDRI aims to further develop and refine this approach for clinical use.
HDRI remains committed to developing reliable diagnostics for Dirofilaria to enable better research, understanding, and eventual treatment of this elusive disease in humans.